update Number of Federal DePuy Pinnacle Lawsuits Nearing 3,000

The Rottenstein Law Group, which represents clients with claims stemming from the surgical implantation of hip replacement devices manufactured and sold by DePuy Orthopaedics and other companies, notes that the number of federal Pinnacle hip device lawsuits has passed 2,500.

A “statistics report” dated November 14, 2012, prepared by the United States Judicial Panel on Multidistrict Litigation to show the distribution of pending Multidistrict Litigation (MDL) dockets reveals that as of the report date there are 2,682 federal actions now pending and consolidated in the United States District Court for the Northern District of Texas (in a matter known as “IN RE: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation,” no. MDL 2244).

According to complaints filed by recipients of DePuy’s Pinnacle hip replacement implants, the devices have loosened prematurely and, like other metal-on-metal hip implants, are releasing potentially toxic particles into patients’ bloodstreams. Pretrial proceedings in MDL 2244 have been progressing apace since the Pinnacle MDL case was created in May 2011, and the first trials of included matters are tentatively scheduled to begin in May 2014. Although the number of lawsuits is regularly increasing, the Pinnacle devices, unlike DePuy’s ASR hip replacements, have not been recalled.

Rochelle Rottenstein, principal of the Rottenstein Law Group, implores anyone with a friend or relative who has received a dangerous hip implant or other medical device to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.



RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.